UK SHARED BUSINESS SERVICES LIMITED has floated a tender for Independent Assessment of Business Case and Technical Plans for Vaccines being Developed as Part of a the Dhsc Uk Vaccines Network Programme. The project location is United Kingdom and the tender is closing on 08 Apr 2024. The tender notice number is PS24068, while the TOT Ref Number is 97881670. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : United Kingdom

Summary : Independent Assessment of Business Case and Technical Plans for Vaccines being Developed as Part of a the Dhsc Uk Vaccines Network Programme

Deadline : 08 Apr 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 97881670

Document Ref. No. : PS24068

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : GBP 100000

Purchaser's Detail

Purchaser : UK SHARED BUSINESS SERVICES LIMITED
Polaris House, North Star Avenue SWINDON SN2 1FF England
United Kingdom
Email :professionalservices@uksbs.co.uk

Tender Details

Title : Independent assessment of business case and technical plans for vaccines being developed as part of a the DHSC UK Vaccines Network Programme

Location Of Contract : United Kingdom

Industry : Research and development services and related consultancy services - 73000000

Value Of Contract : £0 to £100, 000

Description : The final date and time for the submission of bids is Monday, 8th April 2024 at 14:00DO NOT apply directly to the buyer.All tender information MUST be submitted through the Jaggaer eSourcing Portal.Brief Description of RequirementInnovate UK is delivering a component of the ODA funded, UK vaccines Network (UKVN) on behalf of the Department for Health & Social Care (DHSC). To date the UKVN has invested £110M to support the development of vaccines for diseases that have outbreak potential. In the last 8 years IUK have delivered a £85M programme of work, specifically aimed at the development of platforms and vaccines that will have utility in Low- and Middle-Income Countries against diseases of epidemic potential.DHSC have just committed a further £45M, for a 4-year in the programme, to be delivered by IUK, to invest in on-going projects and new platforms and technologies. To reduce the risk of regulatory and technical failure as the projects move through pre-clinical and clinical development, current stage 1 projects will be asked to produce a Business Case and Technical Plan(BC&TP). This will give confiden...

Documents

 Tender Notice